Research reading
Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale demand and the China (CHN) to United States (USA) lane
United States (USA) reported $441.4M of medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale imports in 2024. China (CHN) accounted for 8.3% of the observed market and reported $36.8M in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +8.9% buyer growth and +35.5% exporter growth. The page separates reported values from projections and indicators.
